Cargando…
Expectant management in genitourinary malignancies (prostate, bladder, kidney)
Autores principales: | Van Hemelrijck, Mieke, Kinsella, Netty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261419/ https://www.ncbi.nlm.nih.gov/pubmed/34295756 http://dx.doi.org/10.21037/tau-21-453 |
Ejemplares similares
-
The need for research methodology to improve acceptability of long-term surveillance for cancer
por: Kinsella, Netty, et al.
Publicado: (2021) -
Factors that influence patients’ views on treatment decision-making in localised kidney cancer
por: Beyer, Katharina, et al.
Publicado: (2021) -
Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer
por: Beckmann, Kerri, et al.
Publicado: (2021) -
Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function—a retrospective study in low-risk prostate cancer patients
por: Crump, R. Trafford, et al.
Publicado: (2021) -
Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future?
por: Roobol, Monique J.
Publicado: (2021)